Idalopirdine

N/A

Report date: 2023/08/07 17:46:18
NME

Base Information

Drug NameIdalopirdine
Drug Alias Name伊达吡啶idalopirdineidalopirdinum依达匹定idalopirdina +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonists
TargetsSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsSchizophreniaCognitionAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[38] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesDenovo Biopharma Llc
Inactive CompaniesH. Lundbeck A/SLundbeck (Beijing) Pharmaceutical Consulting Co Ltd
Active IndicationsAlzheimer Disease
Inactive IndicationsSchizophreniaCognition

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG